Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger

Assiut University100 enrolled

Overview

Omitting the GnRH antagonist on the day of the trigger can be cost effective and more convenient to the women. We will study the impact of omitting the antagonist dose in a prospective randomized trial

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

100

Conditions

Pituitary Downregulation

Interventions

Omit Citrotide 0.25 dose on the day of triggering of ovulationDRUG

Omit Citrotide 0.25 dose on the day of triggering of ovulation

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 35 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All antagonist cycle ivf who agree to participate Exclusion Criteria: * expected poor responders.

Locations (2)

Osama Abdalmageed

Asyut, Non-US/Non-Canadian, Egypt

RECRUITING

Osama Abdalmageed

Asyut, Non-US/Non-Canadian, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of retrieved oocytes

total number and maturation of the retrieved oocytes

Time frame: One Month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.